Precision medicine treatment delivers strong results for infantile fibrosarcoma and other solid tumors
Researchers at Children's Hospital of Philadelphia (CHOP) and the Children's Oncology Group (COG) found that larotrectinib, an oral drug that stops cancer-cell growth, was highly effective in pediatric patients with newly ...
Dec 10, 2024
0
12
